Myeloid protocols (printable versions)

(For CLL, please see the lymphoma protocols section)

ADE - ML.1Printable version
ALL Consolidation Cycle 1 - ML.45Printable version
ALL Consolidation Cycle 2 - ML.46Printable version
ALL Consolidation Cycle 3 - ML.47Printable version
ALL Consolidation Cycle 4 - ML.48Printable version
ALL Intensification CNS Prophylaxis - ML.49Printable version
ALL Maintenance - ML.50Printable version
ALL Phase 1 Induction - ML.51Printable version
ALL Phase 1 Induction - ML.52Printable version
ATRA and Arsenic Trioxide - ML.35Printable version
Low Dose Ara-C - ML.30Printable version
Low Dose Ara-C and Clofarabine - ML.32Printable version
ATG in aplastic anaemia (adults)Printable version
ATRA - ML.31Printable version
Azacitidine - ML.38Printable version
Blinatumomab - ML.28Printable version
Bosutinib - ML.44Printable version
Busulfan - ML.42Printable version
ChlorambucilPrintable version
CladribinePrintable version
CLO-ARA-C - ML.3Printable version
Cytarabine (ARA-C) 1.5 g/m2 (high dose) - ML.5Printable version
Cytarabine (ARA-C) 3 g/m2 (high dose) - ML.4Printable version
Cytarabine Intrathecal CNS AML - ML.36Printable version

DA - ML.6Printable version
Dasatinib - ML.7Printable version
Doxorubicin for urgent use - L.58Printable version
Etoposide Oral - ML.37Printable version
EZ - ML.8Printable version
FLA-IDA - ML.9Printable version
FLAG - ML.53Printable version
FLAG-IDA - ML.54Printable version
Gemtuzumab ozogamicin (Mylotarg) - ML.11Printable version
HD Ara-C + Amsacrine - ML.27Printable version
Hydroxycarbaide - ML.29Printable version
Imatinib (Glivec) - ML.12Printable version
Interferon & PEG/Interferon - ML.57Printable version
Lenalidomide MDS - ML.39Printable version
MACE - ML.13Printable version
Methotrexate (high dose) - genericPrintable version
Methotrexate (intrathecal)Printable version
MidAC - ML.14Printable version
Nelarabine - ML.15Printable version
Nelarabine Cyclophosphamide Etoposide - ML.58Printable version
Nilotinib - ML.16Printable version
PentostatinPrintable version
Ponatinib - ML.41Printable version
Ruxolitinib - ML.43Printable version

Return to Myeloid page   Return to Home page